当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析 - 现金流量表

福元医药

(601089)

  

流通市值:31.58亿  总市值:73.82亿
流通股本:2.05亿   总股本:4.80亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,516,657,281.731,664,006,015.3826,072,528.163,205,113,243.45
收到的税费返还1,526,178.941,526,178.94833,878.943,550,708.96
收到其他与经营活动有关的现金69,334,371.1858,283,865.5936,690,917.87100,475,262.83
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,587,517,831.851,723,816,059.83863,597,324.973,309,139,215.24
购买商品、接受劳务支付的现金540,573,858.31379,604,421.09173,857,616.94533,322,152.43
支付给职工以及为职工支付的现金486,338,848.09337,358,018.25209,135,042.33585,701,186.86
支付的各项税费230,602,764.06159,649,705.5382,891,307.12380,838,872.08
支付其他与经营活动有关的现金839,997,967.32500,970,095.94253,830,314.061,253,376,391.77
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,097,513,437.781,377,582,240.81719,714,280.452,753,238,603.14
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额490,004,394.07346,233,819.02143,883,044.52555,900,612.1
二、投资活动产生的现金流量:
取得投资收益收到的现金5,061,481.83--2,418,589.04
处置固定资产、无形资产和其他长期资产收回的现金净额9,963,375.029,807,7428,571,117.5520,088.62
收到的其他与投资活动有关的现金1,145,998,981.92--388,617,800
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,161,023,838.779,807,7428,571,117.5391,556,477.66
购建固定资产、无形资产和其他长期资产支付的现金281,547,410.29182,818,231.6599,900,685.86366,075,648.69
支付其他与投资活动有关的现金2,448,000,0001,060,000,000-411,137,581.92
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,729,547,410.291,242,818,231.6599,900,685.86777,213,230.61
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,568,523,571.52-1,233,010,489.65-91,329,568.36-385,656,752.95
三、筹资活动产生的现金流量:
取得借款收到的现金49,900,00049,900,00039,900,00055,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计49,900,00049,900,00039,900,00055,000,000
偿还债务支付的现金72,303,678.8157,471,954.1145,000,00044,943,908.22
分配股利、利润或偿付利息支付的现金236,301,708.71235,905,880.76411,446.58194,595,180.13
支付其他与筹资活动有关的现金193,489,725.48159,553,052.78155,886,770.4922,143,732.37
筹资活动现金流出平衡项目0000
筹资活动现金流出小计502,095,113452,930,887.65201,298,217.07261,682,820.72
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-452,195,113-403,030,887.65-161,398,217.07-206,682,820.72
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,530,714,290.45-1,289,807,558.28-108,844,740.91-36,438,961.57
加:期初现金及现金等价物余额2,504,500,364.082,504,500,364.082,504,500,364.082,540,939,325.65
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额973,786,073.631,214,692,805.82,395,655,623.172,504,500,364.08
补充资料:
净利润-292,438,727.97-492,336,741.15
资产减值准备-1,456,900.33-13,686,141.29
固定资产和投资性房地产折旧-36,113,149.02-69,038,855.41
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-36,113,149.02-69,038,855.41
无形资产摊销-6,062,414.09-10,730,062.24
长期待摊费用摊销-3,371,326.71-7,026,484.03
处置固定资产、无形资产和其他长期资产的损失--8,439,699.79--225,870.16
固定资产报废损失-1,176,539.11-1,226,441.67
财务费用-2,005,160.82-5,369,590.54
投资损失----2,281,687.77
递延所得税-905,083.93-1,284,742
其中:递延所得税资产减少-375,407.81-1,912,438.88
递延所得税负债增加-529,676.12--627,696.88
存货的减少--30,085,577.41-17,992,228.67
经营性应收项目的减少-37,082,322.25--23,283,497.97
经营性应付项目的增加--4,319,632.1--49,357,397.54
其他--242,143.24--2,764,926.99
现金的期末余额-1,214,692,805.8-2,504,500,364.08
减:现金的期初余额-2,504,500,364.08-2,540,939,325.65
公告日期2024-10-252024-08-152024-04-242024-04-01
审计意见(境内)标准无保留意见
TOP↑